The r/Esthetics post "If I wanted to learn more about getting into device sales, where do I even start?" is one sentence long, and it describes a career move that far more estheticians consider than act on. The author is a working esthetician who wants to branch out, has noticed device sales as an option, and wants to know where the door is.
It is a reasonable move, and estheticians are unusually well positioned for it โ but the role is not what most people picture when they hear "sales," and the difference determines whether the transition works.
First, find out which of the two markets the job is in
Device sales splits into two businesses that share vocabulary and almost nothing else.
Capital equipment means the machines: high ticket, few units per practice, long consideration periods, and decisions made by owners or medical directors who are thinking about financing, room space, staffing and payback. A single sale can take months and involves more than one person.
Consumables and disposables mean the cartridges, tips, gels, needles, handpieces and lotions that the machine requires: small ticket, high volume, frequent reorder, decisions made by the practitioner who uses them. The relationship is continuous rather than episodic, and the sale is more about reliability and never running out than about persuasion.
Most roles lean one way, and the day-to-day is completely different. A capital equipment rep spends the week qualifying opportunities and building a business case. A consumables rep spends it managing a book of accounts and a reorder rhythm. Before accepting anything, it is worth establishing which one the role actually is โ because discovering the answer in month two is expensive.
Three kinds of employer, with different support behind you
The manufacturer, selling directly. Tighter product focus, usually the best training and the strongest service and parts infrastructure, and a defined territory. The trade is narrower scope: you learn one line deeply.
The distributor or sales organization, carrying multiple lines. Broader catalogue, often broader territory, more autonomy, and thinner support when something goes wrong. The advantage is that you can solve more problems for a client; the risk is that you are the one absorbing the complications.
The independent representative, carrying lines on your own account. Highest autonomy and highest exposure, sometimes with consignment or demonstration units to manage. This is the version where a bad month is genuinely your own problem.
The question that separates them in practice is not the product line but the failure path. Every machine eventually breaks. Before joining, establish who handles service and parts, how fast a repair happens, what the client is told while waiting, and whether the rep is expected to manage that or whether someone else owns it. The answer determines whether an account renews, and retention is where the real earnings are.
What genuinely transfers from the treatment room
The value of an esthetician or nurse in this role is not that she can sell. It is that she can answer the questions a non-clinical salesperson cannot.
An owner evaluating a device wants to know whether it fits a sixty-minute service that already exists, whether it fits a single-treatment-room suite, what it adds to consumable costs per appointment, whether the staff can be trained on it, and how many treatments per week it needs to run to cover its own financing. An esthetician has lived all of those constraints. She also knows the difference between what a machine's spec sheet promises and what a full appointment with it actually consumes in time and product.
There is a second advantage that is worth more than it sounds: knowing where the scope line falls. An owner who buys a machine the staff cannot legally operate has bought a very expensive piece of furniture, and a rep who raises that question before the sale โ rather than after โ is treated as a resource rather than a vendor. That is the kind of credibility that makes an account yours for years. It also needs care: scope, supervision and device rules vary by state and change, so the rep's role is to flag the question and point the client at the board rather than to deliver a verdict.
What does not transfer
Loving the equipment is not the job. The job is pipeline management under quota, which means the parts of the work that have nothing to do with treatments: prospecting, follow-up, forecasting, and a great deal of time in a car or on the phone with people who are not ready to decide.
The hardest part is the financial conversation. Practices buy on payback, not on features. Being able to build a simple, honest model โ purchase price, financing terms, the price of the service, how many treatments per week it takes to cover the cost, and how that changes if the service is priced lower โ is what turns a demonstration into a decision. A rep who cannot do that arithmetic in front of a client will lose to one who can, regardless of product knowledge.
And there is the inversion that catches first-time reps: the first sale is much easier than the eighth. Closing a new account depends on the pitch; keeping one depends on training, service and whether the machine is actually earning. Reps who are good at the first and indifferent to the second have a high first year and a bad third one.
How to evaluate an offer
Compensation structures in equipment sales vary widely, so the useful exercise is not to look for a norm but to ask enough questions to understand the risk. Is the base salary fixed, commission-only, or a draw against future commission that has to be earned back. How exactly is the territory defined, and is it exclusive. Does the rep own the account relationship or does the company. What is actual quota attainment across the team rather than the target. Are leads supplied or is prospecting cold. Are demonstration units available for trials, since a device that cannot be demonstrated is much harder to sell. What is covered for travel and mileage. What is the realistic ramp โ how many months before the pipeline produces.
The structure that looks most attractive in the headline is often the one with the most risk underneath, and any offer is worth having reviewed by someone who knows employment and commission law where you live before signing.
How to actually get in
The entry point is almost never a job board. It is the accounts already in your life.
The reps who sold equipment to your own practice or employer, the trainer who trained you on the machines you use, the distributor who services them, the manufacturer's territory manager who visits โ these people know who is hiring, they are often compensated for referrals, and they have already observed you using their product competently. An esthetician with a working knowledge of several device lines and a relationship with the people who sell them is a known quantity, which is a decisive advantage over a CV from outside the industry.
Two things make that conversation go well. First, know the landscape: the major modalities, what each is for, which ones carry supervision requirements, and the rough price tiers and financing norms in your market. That knowledge comes free with having worked in the industry. Second, be able to talk numbers โ payback per treatment, treatments per week to break even, consumable cost per appointment. An interview that includes the client's payback arithmetic is a different interview from one that includes enthusiasm.
A test to run before committing
Three questions cover most of the risk. Ask how service and parts are handled and who owns that call. Ask to speak with two existing reps and ask them what percentage of their accounts renewed last year. And ask what happens in the first two months if nothing sells, and what the company considers a normal ramp.
The answers separate a role where you inherit a territory with a service infrastructure from one where you are the entire support system for a product nobody can keep running. For an esthetician who can speak both the treatment language and the payback arithmetic, the first kind of role is very much available โ and the reason to take it is that the combination is rarer than either half on its own.